Local view for "http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugs/DB08816"

Predicate	Value (sorted: none)
drugbank:description	"Ticagrelor (trade name Brilinta in the US, Brilique and Possia in the EU) is a platelet aggregation inhibitor produced by AstraZeneca. Unlike clopidogrel, ticagrelor is not a prodrug and does not require metabolic activation. The drug was approved for use in the European Union by the European Commission on December 3, 2010. The drug was approved by the US Food and Drug Administration on July 20, 2011."
owl:sameAs	drug:Lomitapide
rdf:type	drugbank:drugs
owl:sameAs	drug:Etravirine
drugbank:interactsWith	drug:Simvastatin
drugbank:interactsWith	drug:Etravirine
drugbank:interactsWith	drug:Lovastatin
owl:sameAs	drug:Simvastatin
owl:sameAs	drug:Lovastatin
rdfs:label	"Ticagrelor"
owl:sameAs	drug:Conivaptan
drugbank:drugCategory	drugcategory:Platelet Aggregation Inhibitors
drugbank:interactsWith	drug:Conivaptan
drugbank:interactsWith	drug:Lomitapide

All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines3/drugbank_small.nt

The resource appears as object in 10 triples

Context graph